Risedronate Sodium (Apotex Corp.)


Welcome to the PulseAid listing for the Risedronate Sodium drug offered from Apotex Corp.. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Apotex Corp.
NON-PROPRIETARY NAME: Risedronate Sodium
SUBSTANCE NAME: RISEDRONATE SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2014-06-11
END MARKETING DATE: 0000-00-00


Risedronate Sodium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRisedronate Sodium from Apotex Corp.
LABELER NAME: Apotex Corp.
DEA SCHEDULE:
ACTIVE STRENGTH: 75(mg/1)
START MARKETING DATE: 2014-06-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60505-3096_1da1085d-93a4-d093-60fc-500db3d70cea
PRODUCT NDC: 60505-3096
APPLICATION NUMBER: ANDA090877

Other RISEDRONATE SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Apotex Corp.Risedronate Sodium
Aurobindo Pharma LimitedRisedronate Sodium
Macleods Pharmaceuticals LimitedRisedronate Sodium
Mylan Pharmaceuticals Inc.Risedronate Sodium
Physicians Total Care, Inc.Actonel
Warner Chilcott Pharmaceuticals Inc.ACTONEL